Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prev close 4.51 · gapped above the open, then crossed back over prior close. High/low 4.69 at 7:45 am ET, 4.42 at 11:00 am ET.
Sources
sec edgar · verbatim disclosureEach tie, with the sentence that disclosed it. Open a row for the wording and the filing it came from.
“We received an upfront non-refundable payment from AbCellera of $6.5 million upon signing the Amended Agreement and an upfront non-refundable payment of $6 million upon signing of the Expanded License Agreement.”
FILING10-K0001193125-26-099428cik 0001678660
“For example, we received capital in connection with the exclusive option agreement entered into with Incyte Corporation ("Incyte") in November 2025 in exchange for the option to acquire certain rights, titles and interests related to our mutative selective JAK2V617F inhibitor program.”
FILING10-K0001193125-26-099428cik 0001678660
“Pathos will pay us milestone payments upon the achievement of specified development and sales milestone events, as well as royalties on sales of the licensed products.”
FILING10-K0001193125-26-099428cik 0001678660
“In March 2023, in connection with filing a prospectus supplement to our 2021 Shelf Registration Statement, we entered into an Open Market Sales Agreement (the "Sales Agreement") with Jefferies LLC, as the sales agent, pursuant to which we may offer and sell shares of our common stock having an aggregate offering amount of up to $75.0 million.”
FILING10-K0001193125-26-099428cik 0001678660
“Other income, net consists primarily of interest earned on our cash equivalents and marketable securities, research and development tax credits, and grant income received from the State of Delaware.”
FILING10-K0001193125-26-099428cik 0001678660
Watchlist prices, news filtered to it, and its next report on your desk.
Prelude Therapeutics Inc
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
Prelude Therapeutics Inc has 2 disclosed suppliers and 3 disclosed customers. Each one is named in an SEC filing, either Prelude Therapeutics Inc’s own annual report or the counterparty’s, and carries the sentence that discloses it.
PRLD (Prelude Therapeutics Inc) has 2 disclosed suppliers and 3 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: JEF −2.47%, in financials.